Literature DB >> 1660064

The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.

K B Yeung1, P K Thomas, R H King, H Waddy, R G Will, R A Hughes, N A Gregson, S Leibowitz.   

Abstract

Observations have been made on a consecutive series of 62 patients with peripheral neuropathy associated with benign monoclonal paraproteinaemia. The paraprotein class was IgM in 46 cases, IgG in 11 and IgA in 5. Although showing variations between patients, the clinical picture was similar for those with either IgM or IgG paraproteins, usually consisting of a late-onset, slowly progressive, distal sensorimotor demyelinating polyneuropathy, often with tremor and ataxia as prominent features. Tremor was slightly more common in patients with IgM paraproteins, in whom there was a male preponderance. The patients with both paraprotein classes were indistinguishable clinically and electrophysiologically from chronic idiopathic demyelinating polyneuropathy. In the 5 patients with an IgA paraprotein, there was a distal sensorimotor neuropathy in 4 which was demyelinating in 1. In 1 there was proximal demyelinating motor neuropathy. Immunoglobulin deposition on myelin was observed only in the patients with IgM paraproteinaemia, more commonly with a kappa light chain. No deposition of immunoglobulin in the endoneurium was seen. IgM deposits on the perineurium are a feature of normal nerve and were present in all cases. Widely spaced myelin was confined to cases with IgM paraproteins in which immunoglobulin deposition was detected on myelin. The response to treatment could not be assessed systematically but, in general, the patients with IgG and IgA paraproteins responded more satisfactorily (to corticosteroids, cytotoxic drugs, or plasma exchange) than did those with an IgM paraprotein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660064     DOI: 10.1007/bf00319857

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  56 in total

1.  Basic two-dye stains for epoxy-embedded 0.3-1 sections.

Authors:  J Sievers
Journal:  Stain Technol       Date:  1971-07

2.  IgM paraproteinemia and autoimmune peripheral neuropathy.

Authors:  S N Kahn; I A Smith; R A Eames; P K Thomas; B W Lacey
Journal:  N Engl J Med       Date:  1981-06-04       Impact factor: 91.245

3.  The occurrence and significance of myelin with unusually large periodicity.

Authors:  R H King; P K Thomas
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  Cryptogenic fibrosing alveolitis associated with peripheral neuropathy.

Authors:  C Turton; J M Jacobs
Journal:  Q J Med       Date:  1983

5.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

6.  Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis.

Authors:  W H Sherman; N Latov; A P Hays; M Takatsu; R Nemni; G Galassi; E F Osserman
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

7.  Peripheral neuropathy associated with immunoglobulin disorders an immunological and ultrastructural study.

Authors:  E Nardelli; S Pizzighella; G Tridente; N Rizzuto
Journal:  Acta Neuropathol Suppl       Date:  1981

8.  Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy.

Authors:  M Reulecke; M Dumas; C Meier
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

9.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

10.  Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin.

Authors:  B D Trapp; R H Quarles
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

View more
  23 in total

Review 1.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  G Comi; L Roveri
Journal:  Ital J Neurol Sci       Date:  1998-10

2.  Successful treatment of IgM paraproteinaemic neuropathy with fludarabine.

Authors:  H C Wilson; M P Lunn; S Schey; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

3.  Waldenstrom-associated anti-MAG paraprotein polyneuropathy with neurogenic tremor.

Authors:  Carlo Canepa
Journal:  BMJ Case Rep       Date:  2019-03-31

4.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

Review 5.  Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.

Authors:  Hafsa M Chaudhry; Michelle L Mauermann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2017-05       Impact factor: 7.616

Review 6.  Advances in the Treatment of Paraproteinemic Neuropathy.

Authors:  Eduardo Nobile-Orazio; Mariangela Bianco; Andrea Nozza
Journal:  Curr Treat Options Neurol       Date:  2017-10-16       Impact factor: 3.598

Review 7.  Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

Authors:  Michael Pt Lunn; Eduardo Nobile-Orazio
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

8.  Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells.

Authors:  Eva Hellqvist; Maria Kvarnström; Anita Söderberg; Magnus Vrethem; Jan Ernerudh; Anders Rosén
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

9.  Analyzing Relationship Between Monoclonal Gammopathy of Undetermined Significance (MGUS) with Different Types of Neuropathy: An Observational Study.

Authors:  Shahzaib Nabi; Pushpinderdeep Kahlon; Farshid Bozorgnia; Adeel Arshad; Akmam Saleem; Philip Kuriakose
Journal:  Indian J Hematol Blood Transfus       Date:  2015-05-28       Impact factor: 0.900

Review 10.  Systematic reviews of treatment for inflammatory demyelinating neuropathy.

Authors:  R A C Hughes
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.